This course is developed by Medscape Education Global.
Medscape is one of the leading digital platforms for medical
education. A comprehensive array of innovative formats, in multiple
languages, insures the right educational solution is available to best
achieve desired objectives—from text-based articles to
state-of-the-art multimedia formats and the most sophisticated
simulation environments. Activity formats include Clinical Insights,
Expert Perspective, Instructional Series Programming, Next-Generation
Symposia, Patient-Case Approaches, including Simulation and Clinical Advances.
Data from recent clinical and cardiovascular outcomes trials (CVOTs)
suggest that glucagonlike peptide-1 (GLP-1) receptor agonists have
multi-factorial benefits beyond glycaemic control.
On this programme, you'll find a collection of dynamic, interactive
educational courses addressing the latest evidence for managing
individuals with diabetes and other disordes - especially established
or risk factors for atheroscletoric cardiovascular disease (ASCVD) and
chronic kidney disease (CKD)
Made for: Specialists, Primary Care Physicians
Disease areas: Diabetes, Cardiovascular Disease, Chronic Kidney Disease
Developed by: Medscape Education Global